Medication info
Tagamet Tablets 200 Milligrams (Cimetidine)

Tagamet Tablets 200 Milligrams (Cimetidine)

Prescription medicationTabletOral
Ingredient · strength
Cimetidine›200mg / 1 tablet
Manufacturer / importer
(Stock Company) Yuhan Corporation
Appearance
Grayish white to pale green round film-coated tablet
Packaging
100 tablets/bottle
Approval status
Active

MFDS item code 198401253 · Notified 1984.04.23 · Insurance code 642105000

Summary

Main use
Treats acid-related disorders (ulcers, reflux esophagitis, etc.) and improves gastric mucosal lesions in gastritis
Who takes it
Adults · Children
Adult dose
Adults: Administer 400 mg of cimetidine orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg per dose 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions—acute gastritis and the acute exacerbation phase of chronic gastritis—administer 200 mg per dose twice daily or 400 mg once daily. An antacid may be administered as needed for pain relief. The dose may be increased in some patients; in such cases, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medicine per dose twice daily, every 12 hours. If necessary according to the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more often, but use caution. In patients with severe renal impairment, the medicine may accumulate in the body; therefore, reduce the frequency of administration to a minimum according to the patient's response. Hemodialysis lowers blood cimetidine levels. After hemodialysis is completed, readminister the medicine according to the schedule. Adjust the dose as appropriate according to age and symptoms.
Child dose
Children: Administer 20 〜 40 mg per kg of body weight per day orally in divided doses.

Ingredients

Manufacturer
(Stock Company) Yuhan Corporation

Efficacy & effects

Treats acid-related disorders (ulcers, reflux esophagitis, etc.) and improves gastric mucosal lesions in gastritis

  • Gastric and duodenal ulcers
  • gastroesophageal reflux disease
  • recurrent ulcers
  • anastomotic ulcers
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosions
  • bleeding
  • redness
  • swelling
  • acute gastritis
  • acute exacerbations of chronic gastritis
View approved original text

This medication is effective for conditions such as ulcers in the stomach and duodenum, gastroesophageal reflux disease, recurrent ulcers, anastomotic ulcers following surgery, and Zollinger-Ellison syndrome. It is also used to improve lesions in the gastric mucosa during acute exacerbations of acute gastritis or chronic gastritis, such as erosions, bleeding, redness, and swelling. In summary, it is a widely used medication for treating ulcers and inflammatory lesions related to the stomach and duodenum, helping to improve patients' gastrointestinal health.

How to take

Adult dose

Adults: Administer 400 mg of cimetidine orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg per dose 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions—acute gastritis and the acute exacerbation phase of chronic gastritis—administer 200 mg per dose twice daily or 400 mg once daily. An antacid may be administered as needed for pain relief. The dose may be increased in some patients; in such cases, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medicine per dose twice daily, every 12 hours. If necessary according to the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more often, but use caution. In patients with severe renal impairment, the medicine may accumulate in the body; therefore, reduce the frequency of administration to a minimum according to the patient's response. Hemodialysis lowers blood cimetidine levels. After hemodialysis is completed, readminister the medicine according to the schedule. Adjust the dose as appropriate according to age and symptoms.

Child dose

Children: Administer 20 〜 40 mg per kg of body weight per day orally in divided doses.

Precautions

This medication can introduce glass fragments when using glass ampoule injections, so extra caution is needed, especially for children and the elderly. It should not be administered to patients with hypersensitivity to this medication or allergies to cimetidine, nor to patients currently taking dofetilide. Patients with impaired kidney or liver function, older adults, children under 19 years old, and those undergoing hemodialysis should use the drug with caution, requiring dose and administration interval adjustments. This medication can cause a variety of side effects such as reduced blood cell count, liver dysfunction, kidney impairment, hypersensitivity reactions, gynecomastia, gastrointestinal symptoms, neurological disturbances, and skin reactions. Therefore, if any abnormal symptoms occur, patients should consult healthcare professionals immediately. During treatment, it is important to monitor the course of the disease closely, and if there is no effect, other treatment options may be considered. Regular checks of liver and kidney function, as well as blood status, are crucial. This medication can interact with various drugs, especially anticoagulants, sedatives, antidepressants, antiarrhythmics, and diabetes medications, so dosage adjustments or discontinuation may be necessary in consultation with a doctor or pharmacist. Women who are pregnant or may become pregnant should only use this medication when the benefits outweigh the potential risks to the fetus since the effect on the fetus is not clearly established. Nursing mothers are advised to discontinue breastfeeding while taking this medication. Safety for pediatric patients has not been sufficiently established, so it should only be administered cautiously when necessary. Elderly patients often have reduced kidney function, which can lead to increased drug concentration, so it may be necessary to reduce the dose or extend the dosing interval. In the case of overdose, serious side effects such as respiratory depression may occur, so immediate emergency assistance is required if suspected. When administered in injection form, rapid intravenous injection should be avoided and given slowly to reduce the risk of side effects. Store out of reach of children, and transferring to other containers can jeopardize the quality and safety of the drug, so caution is advised.

Side effects

  • Leukopenia
  • agranulocytosis
  • aplastic anemia
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • systemic weakness
  • asthenia
  • subcutaneous hemorrhage
  • mucosal hemorrhage
Show 52 more
  • fever
  • immune hemolytic anemia
  • jaundice
  • hepatitis
  • elevated AST
  • elevated ALT
  • abnormal liver function
  • perivascular hepatic fibrosis
  • interstitial seizures
  • acute renal failure
  • interstitial nephritis
  • urinary retention
  • elevated BUN
  • elevated serum creatinine
  • shock
  • anaphylactic-like reaction
  • hypersensitivity vasculitis
  • rash
  • gynecomastia
  • galactorrhea
  • increased vaginitis
  • erectile dysfunction
  • abdominal fullness
  • constipation
  • diarrhea
  • headache
  • dizziness
  • convulsions
  • limb paresthesia
  • stiffness
  • drowsiness
  • hypochondriacal symptoms
  • altered consciousness
  • delirium
  • bradycardia
  • tachycardia
  • palpitations
  • atrioventricular block
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • epidermal necrosis
  • erythema multiforme
  • exfoliative dermatitis
  • generalized exfoliative erythema
  • fatigue
  • generalized heat sensation
  • dysuria
  • myalgia
  • arthralgia
  • pancreatitis
  • hair loss
  • polymyositis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air from entering, preferably at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain its effectiveness and prevent deterioration.

Appearance and packaging

Appearance

Grayish white to pale green round film-coated tablet

Package unit

100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.